Navigation Links
IGF-1 and Long IGF-1 LR3 Is There a Difference? US Peptides Discusses
Date:2/8/2013

TAMPA, Fla., Feb. 8, 2013 /PRNewswire-iReach/ -- Research peptides are used around the world for a number of reason but most notably to test the effects of growth hormone related hormones and growth hormone related peptides and their effects.

(Photo: http://photos.prnewswire.com/prnh/20130208/CG56993)

US Peptides carries a variety of products such as: Melanotan II, CJC-1295, GHRP-6, Sermorelin, IGF1-LR3, GHRP-2, Fragment 176-191, CJC-1295 DAC, Mechano Growth Factor – PEG, Mechano Growth Factor, Hexarelin, Ipamorelin, Melanotan I, Bacteriostatic 0.9% Sodium Chloride and hard to find Bacteriostatic Water.

Growth factors like IGF play an important role in childhood, specifically puberty. IGF is responsible for natural muscle growth that occurs during puberty, along with other functions like increased glucose transport, increased protein synthesis, increased RNA synthesis, increased amino acid transport to cells, and decreased protein degradation.

However, there are different forms of IGF, such as IGF-1 and IGF-1 LR3 that have varied potencies and functions.

IGF-1

Insulin-like Growth Factor 1, abbreviated IGF-1, is a protein that is encoded by the IGF1 gene. It consists of 70 amino acids and is a hormone that is structured similarly to insulin. Its main function is to stimulate growth within the body due to its regulation of both cell growth and cell death.

Synthetic IGF-1 serves as an alternative to solely relying on the pituitary gland to make Human Growth Hormone (HGH). The pituitary gland decreases function with age, but the IGF-1 bypasses that organ and produces the same effects of growth hormone.

IGF-1 Long R3

IGF-1 Long R3, or IGF-1 LR3, is a form of IGF that has been chemically altered with changed amino acids. It consists of 83 amino acids with a substation of Arg(R) for the Glu(E) at position three, hence, the name R3. The altercations enable it to avoid binding to proteins in the body, which allows it to have a longer half-life.

IGF-1 LR3 is more potent than the regular IGF-1 because of the decreased binding of Long R3 IGF-1 to IGF binding proteins. Its main purpose is to increase the biological activity of IGF.

Essentially, when IGF-1 LR3 is active in the body, it functions differently in different types of tissues. For instance, in muscle tissue, it makes the muscle more sensitive to insulin's effects, such as a reduction in fat storage. But while IGF-1 LR3 helps fat reduction, a person using it will experience weight gain because of the increase in pure-muscle weight.

Click this link to read more about IGF-1 and IGF-1 LR3

US Peptides is proud to offer high quality research grade peptides like IGF-1 LR3 for research purposes.

USPeptides.com is a United States based distributor of the highest grade research Peptides and Amino Acid Derivatives available. We utilize the most advanced techniques to ensure fast and secure product delivery. These items are intended for research purposes only.

To place an order or learn more please click here, 10% off any purchase of 10 items or more- http://uspeptides.com/



Media Contact: Don Pierce US Peptides LLC, 727-210-7821, info@useptides.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE US Peptides LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Theres a Robot Helping People who Suffer from Hip Pain
2. Are there HCG diet dangers? US HCG Injections Takes a Look.
3. US Peptides Increases Inventory on Sterile Bacteriostatic Water
4. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
5. MDHI Provides Investor Update -- Provides Business Model Overview -- Discusses Upcoming Profitability
6. Dallas Car Wreck Lawyer Discusses Serious Consequences of Driving While Under the Influence of Drugs
7. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
8. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
9. US Vitamin Injections Discusses Bursitis Treatment with B12 Shots
10. Herborium(R) Group Discusses an Aftermath of the Ban of Diane-35 Acne Drug Due to Number of Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/28/2017)... Sept. 28, 2017 Hill-Rom Holdings, Inc. (NYSE: ... conference call and webcast on Friday, November 3, 2017, ... and ending at approximately 8:30 a.m. (CDT) / 9:30 ... company,s 2017 financial performance and guidance for 2018, Hill-Rom ... to enhance operational performance, and long-range financial outlook through ...
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), ... solutions, today announced that its MyDario product is expected to appear on ... for when The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco dentists, ... cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated to ... breathing. Oral appliances can offer significant relief to about 75 percent of people ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... The American ... Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium ... 8. , In honor of Morris F. Collen, a pioneer in the field of ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader ... a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were ... 11, 2017. , The annual award competition recognizes editorial and design excellence across a ...
Breaking Medicine News(10 mins):